CIA
BSX icon

Concurrent Investment Advisors’s Boston Scientific BSX Stock Holding History

Concurrent Investment Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed -$9.54K – 1946
2025
Q4 		$9.54K Hold
100
– – ﹤0.01% 1765
2025
Q3 		$9.76K Hold
100
– – ﹤0.01% 1483
2025
Q2 		$10.7K Buy
+100
New +$10.1K ﹤0.01% 1392

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Concurrent Investment Advisors's BSX Position: Q2 2026 in Review

Concurrent Investment Advisors increased its Boston Scientific (BSX) stake by 77% in Q2 2026, buying an estimated $1.31M and bringing the position to 55,565 shares worth $2.37M. The position accounts for 0.02% of the portfolio, ranked #670.

Concurrent Investment Advisors first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.8M in Q4 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Concurrent Investment Advisors held 55,565 shares of Boston Scientific worth $2.37M as of Q2 2026.
  • Concurrent Investment Advisors bought 24,166 Boston Scientific shares in Q2 2026, an estimated $1.31M.
  • Boston Scientific made up 0.02% of Concurrent Investment Advisors's portfolio in Q2 2026, its #670 holding.
  • Concurrent Investment Advisors first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
  • Concurrent Investment Advisors's Boston Scientific position peaked at $2.8M in Q4 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.